DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 204 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,496,000 | -46.2% | 74,186 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $2,783,000 | +95.2% | 74,186 | +33.0% | 0.00% | +50.0% |
| Q1 2021 | $1,426,000 | -1.7% | 55,786 | -15.3% | 0.00% | 0.0% |
| Q4 2020 | $1,451,000 | +22.4% | 65,880 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,185,000 | -29.2% | 65,880 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,673,000 | +42.1% | 65,880 | +2.8% | 0.00% | 0.0% |
| Q1 2020 | $1,177,000 | -27.1% | 64,080 | -12.6% | 0.00% | 0.0% |
| Q4 2019 | $1,614,000 | +104.3% | 73,280 | +33.3% | 0.00% | +100.0% |
| Q3 2019 | $790,000 | -6.2% | 54,980 | +2.8% | 0.00% | 0.0% |
| Q2 2019 | $842,000 | +55.4% | 53,480 | +44.6% | 0.00% | 0.0% |
| Q1 2019 | $542,000 | +220.7% | 36,980 | +134.1% | 0.00% | – |
| Q4 2018 | $169,000 | – | 15,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |